Skip to main content
ME

Mekonos

Alameda, United States
Last funding
$25.0M
Series ANov 2021

Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.

About Mekonos

How much funding has Mekonos raised?

Mekonos has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.

Who are Mekonos's investors?

Mekonos's investors include TDK Ventures, Sands Capital Ventures, Novartis, Creative Destruction Lab, S32.

Where is Mekonos headquartered?

Mekonos is headquartered in Alameda, United States.

What does Mekonos do?

Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.

What stage is Mekonos at?

Mekonos is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Mekonos — Funding & Investors." VCBacked, November 9, 2021, https://www.vcbacked.co/company/mekonos. Accessed November 17, 2026.
APA
VCBacked. (2021). Mekonos — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/mekonos
Wikipedia (cite web)
{{cite web |title=Mekonos — Funding & Investors |url=https://www.vcbacked.co/company/mekonos |website=VCBacked |access-date=November 17, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Mekonos? Request a listing update

Founder contacts
m***@mekonos.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →